Citi analyst Wendy Nicholson raised the price target on Clorox (NYSE: CLX) to $171.00 (from $169.00) while maintaining a Neutral rating following model updates.

Nicholson maintained FY19 EPS estimate of $6.30. She also maintained FY20 EPS estimate of $6.70 and FY21 EPS estimate of $7.10.

Analyst Comments Analyst PT Change

Clorox (CLX) PT Raised to $139 at RBC CapitalFebruary 5, 2019 6:50 AM Increasing unusual call option volume: MMC CLX ESI EBAY IQV SYYFebruary 4, 2019 10:47 AM Clorox (CLX) Tops Q2 EPS by 10c, Revenues Beat; Confirms FY19 EPS Mid-Point Guidance Below ConsensusFebruary 4, 2019 6:32 AM Clorox Reports Second-Quarter Fiscal Year 2019 Results, Confirms OutlookFebruary 4, 2019 6:30 AM Clorox (CLX) option implied volatility elevated on more calls than puts into EPSFebruary 1, 2019 11:08 AM Clorox (CLX) option implied volatility elevated into EPS and outlookFebruary 1, 2019 5:18 AM